In an exclusive video interview with VCCircle, Dr A Velumani, founder and chairman of Thyrocare Technologies Ltd, explains the rationale behind going B2C and acquisition plans as well as talks on exploring a strategic sale. Thyrocare, India's largest thyroid testing company, is floating a chain of laboratories called Lab Nation, which will follow a business to consumer (B2C) model. CX Partners invested in the company in 2010, picking up the stake from promoters with some primary infusion. Early last year, Nueclear Healthcare Ltd, the low-cost cancer diagnosis services business of the Thyrocare group, raised Rs 22 crore ($4 million) from Norwest Venture Partners. The firm is planning to set up 120 molecular imaging centres for offering low-cost cancer diagnosis services.
- Masterclass on Modern and Traditional Credit Risk Analysis and Management, Digital Masterclass, 12 Mar, 2021
- Mastering Due Diligence for PE/VC and M&A Deals , Digital Training, 19 Mar, 2021
- Technology Investment Summit 2021, Virtual Event, 25 Mar, 2021
- Workshop on PE/VC Fundraising, Negotiation & Deal Documentation, Digital Training, 23 Apr, 2021